Abstract 6501: Development and characterization of covalent inhibitors of the RAS-PIK3CA interactionJoseph E. Klebba, Matt Patricelli, Kelsey N. Lamb et al.|Cancer Research|2024Cited by 1
Abstract C081: Discovery and characterization of AKT1-E17K mutant-selective inhibitors for the treatment of AKT1-E17K mutant cancersTine Wyseure, Matt Patricelli, Noah Ibrahim et al.|Molecular Cancer Therapeutics|2025Cited by 0